AperçuGraphiqueActualitésTraderScreen

Soc. Generale Knock-Out PHARM/  DE000SW9VUL3  /

EUWAX
11/11/2024  11:58:27 Chg.+0.010 Bid11/11/2024 Demandez à11/11/2024 Sous-jacent Prix d'exercice Date d'expiration Type d'option
0.360EUR +2.86% 0.360
Bid taille: 25,000		 0.360
Ask la taille: 25,000		 Pharming Group 1.1023 EUR 31/12/2078 Put
GlobeNewswire 01/08 Pharming Group reports second quarter and first half 2024 financial results and provides business up...
GlobeNewswire 18/07 Pharming Group to report second quarter and first half 2024 financial results on August 1
GlobeNewswire 03/06 Pharming Group to participate in June investor conferences
GlobeNewswire 21/05 Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
GlobeNewswire 20/05 Pharming Group to participate in May investor conference
GlobeNewswire 08/05 Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire 24/04 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire 08/04 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GlobeNewswire 03/04 Pharming Group to participate in April investor conferences
GlobeNewswire 14/03 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 29/02 Pharming Group to report fourth quarter and full year 2023 financial results on March 14
GlobeNewswire 08/02 Pharming Group to participate in February investor conferences
GlobeNewswire 08/01 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
GlobeNewswire 13/12/2023 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...
GlobeNewswire 21/11/2023 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...
GlobeNewswire 13/11/2023 Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Acc...
GlobeNewswire 01/11/2023 Pharming Group to participate in November investor conferences
GlobeNewswire 26/10/2023 Pharming Group reports third quarter 2023 financial results
GlobeNewswire 12/10/2023 Pharming Group to report third quarter 2023 financial results on October 26
GlobeNewswire 25/09/2023 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
GlobeNewswire 10/01/2022 Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene The...
GlobeNewswire 04/11/2021 Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Upd...
GlobeNewswire 04/08/2021 Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Up...
GlobeNewswire 29/07/2021 Oncorus Expands its Board with Appointment of Barbara Yanni
GlobeNewswire 01/07/2021 Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo ...